—

SCHOTT Pharma AG & Co. KGaA (1SXP.DE) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for 1SXP.DE, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
Who it is priced against Medical Instruments & Supplies · Germany · 4 names with week and year-to-date

Peer group

Medical Instruments & Supplies · Germany

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against 1SXP.DE on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — SCHOTT Pharma AG & Co. KGaA

1SXP.DE in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
SCHOTT Pharma makes glass and polymer containers and delivery systems that hold injectable drugs, such as syringes, cartridges, vials and ampoules. Its customers are pharmaceutical, biotech and life-science companies that need packaging able to withstand cold storage, sterilisation or long shelf life. It also offers analytical and fill-and-finish services around these containers. The company is based in Mainz, Germany, and was founded in the nineteenth century.
Where it sits in the stack
SCHOTT Pharma has no seat in our index; it belongs to the healthcare sleeve of our universe, within medical instruments and supplies rather than the AI build-out stack.
Who it is priced against
There is no peer group set for this name in our records; the comparison the market draws is with Gerresheimer, another maker of pharmaceutical glass and polymer packaging.
Why Closelooknet tracks it
It carries no Closelooknet index seat and no score yet; the diary has not quoted it in an edition so far.
What the diary watches
Whether demand for biologics and cold-chain injectables keeps container volumes rising, and whether raw glass costs feed through to its margins.

SCHOTT Pharma AG & Co. KGaA (1SXP.DE) trades on the XETRA exchange in Germany.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.72%, annual · last 0.18 EUR on 2026-02-04

Dividends and capital return

What 1SXP.DE pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.18 EUR per share · a 0.72% yield on the 2026-10-06 close 1 distribution, paid once a year 2026-10-06
  • Change on the year +12.5% against the prior twelve months prior twelve months 0.16 EUR per share
  • Last distribution 0.18 EUR per share as the price series records it, within days of the ex-date 2026-02-04
  • By calendar year 2025: 0.16 EUR (partial) · 2026: 0.18 EUR to date first distribution recorded in the three-year window: 2025-02-05

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is SCHOTT Pharma AG & Co. KGaA (1SXP.DE)?

SCHOTT Pharma AG & Co. KGaA trades as 1SXP.DE on the XETRA exchange (Germany) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is 1SXP.DE in a Closelooknet index?

Not currently — SCHOTT Pharma AG & Co. KGaA is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does 1SXP.DE trade against its moving averages?

Uptrend stack intact: Trades +8.3% vs the 50-day and +42.1% vs the 200-day average, 3.8% below the 52-week high and +98.5% off the 52-week low; a golden cross printed 71 sessions ago. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does SCHOTT Pharma AG & Co. KGaA compare with its peers?

Against its peer group (Medical Instruments & Supplies · Germany), SCHOTT Pharma AG & Co. KGaA (1SXP.DE) sits 3.8% below its 52-week high, 8.3% above its 50-day average; Carl Zeiss Meditec AG (AFX.DE) is 35.6% below, Sartorius AG VZO O.N. (SRT.DE) is 5.8% below, Gerresheimer AG (GXI.DE) is 37.2% below. Put any of them next to 1SXP.DE in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does SCHOTT Pharma AG & Co. KGaA do?

SCHOTT Pharma makes glass and polymer containers and delivery systems that hold injectable drugs, such as syringes, cartridges, vials and ampoules. Its customers are pharmaceutical, biotech and life-science companies that need packaging able to withstand cold storage, sterilisation or long shelf life. It also offers analytical and fill-and-finish services around these containers. There is no peer group set for this name in our records; the comparison the market draws is with Gerresheimer, another maker of pharmaceutical glass and polymer packaging.

Where does SCHOTT Pharma AG & Co. KGaA sit in the AI build-out?

SCHOTT Pharma has no seat in our index; it belongs to the healthcare sleeve of our universe, within medical instruments and supplies rather than the AI build-out stack. It carries no Closelooknet index seat and no score yet; the diary has not quoted it in an edition so far.

Does SCHOTT Pharma AG & Co. KGaA pay a dividend?

SCHOTT Pharma AG & Co. KGaA has paid 0.18 EUR per share over the last twelve months, paid once a year, a trailing yield of 0.72% on the 2026-10-06 close; the last distribution recorded in the price series was 0.18 EUR on 2026-02-04. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for 1SXP.DE, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.